These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34007697)

  • 1. Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System.
    Olander M; Waring S; Stenehjem DD; Taran A; Ranelli P; Brown JT
    Innov Pharm; 2018; 9(2):1-12. PubMed ID: 34007697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
    Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
    PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
    Roederer MW; Van Riper M; Valgus J; Knafl G; McLeod H
    Per Med; 2012 Jan; 9(1):19-27. PubMed ID: 29783293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
    Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
    Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and attitudes on pharmacogenetics among pediatricians.
    Rahawi S; Naik H; Blake KV; Owusu Obeng A; Wasserman RM; Seki Y; Funanage VL; Oishi K; Scott SA
    J Hum Genet; 2020 May; 65(5):437-444. PubMed ID: 31983733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
    Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications.
    McMahon T; Tucci J
    Pharm Pract (Granada); 2011 Jul; 9(3):141-7. PubMed ID: 24367468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
    Albitar L; Alchamat GA
    BMC Health Serv Res; 2021 Oct; 21(1):1031. PubMed ID: 34592972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
    Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
    BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved.
    Gawronski BE; Cicali EJ; McDonough CW; Cottler LB; Duarte JD
    Front Genet; 2022; 13():1085994. PubMed ID: 36712853
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.